Otsuka Shintaro, Morimoto Chihiro, Nishio Shin-Ya, Morita Shinya, Kikuchi Daisuke, Takahashi Masahiro, Kumakawa Kozo, Arai Yasuhiro, Sano Hajime, Yoshimura Hidekane, Yamamoto Norio, Kondo Shunsuke, Hasegawa Mari, Nishi Tomo, Kitahara Tadashi, Usami Shin-Ichi
Department of Otolaryngology-Head and Neck Surgery, Nara Medical University, Kashihara 634-8522, Japan.
Department of Hearing Implant Sciences, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Genes (Basel). 2025 Jan 6;16(1):57. doi: 10.3390/genes16010057.
BACKGROUND/OBJECTIVES: A heterozygous mutation in the gene is responsible for autosomal dominant non-syndromic hearing loss (DFNA6/14/38) and Wolfram-like syndrome, which is characterized by bilateral sensorineural hearing loss with optic atrophy and/or diabetes mellitus. However, detailed clinical features for the patients with the heterozygous p.A684V variant remain unknown.
We report the clinical details of 14 cases with a heterozygous p.A684V variant in the gene identified from target resequencing analysis of 63 previously reported deafness genes by next-generation sequencing of 15,684 hearing loss patients (mean age 27.5 ± 23.1 years old, 6574 male, 8612 female and 498 for whom information was unavailable).
Among the 14 patients from 13 families with the p.A684V variant, nine were sporadic cases. In addition, we confirmed de novo occurrence of this variant in seven families. This result strongly supports the notion that this variant was located on a mutational hotspot. When comparing previously reported cases of autosomal dominant gene-associated hearing loss, most of the patients in this study showed severe-to-profound bilateral sensorineural hearing loss (genotype-phenotype correlation). Two patients had optic atrophy, while the others did not have any other complications.
The identified heterozygous p.A684V variant appears to be a hotspot mutation and likely to cause severe-to-profound hearing loss in early childhood. Cochlear implantation is considered favorable in cases of hearing impairment due to this variant.
背景/目的:该基因中的杂合突变导致常染色体显性非综合征性听力损失(DFNA6/14/38)和沃尔弗拉姆样综合征,其特征为双侧感音神经性听力损失伴视神经萎缩和/或糖尿病。然而,具有杂合p.A684V变异的患者的详细临床特征仍不清楚。
我们报告了14例具有该基因杂合p.A684V变异的患者的临床细节,这些患者是通过对15684例听力损失患者(平均年龄27.5±23.1岁,男性6574例,女性8612例,498例信息不详)进行下一代测序,对63个先前报道的耳聋基因进行靶向重测序分析而确定的。
在13个携带p.A684V变异的家族的14例患者中,9例为散发病例。此外,我们在7个家族中证实了该变异的新发。这一结果有力地支持了该变异位于突变热点的观点。与先前报道的常染色体显性该基因相关听力损失病例相比,本研究中的大多数患者表现为重度至极重度双侧感音神经性听力损失(基因型-表型相关性)。2例患者有视神经萎缩,其他患者无任何其他并发症。
已鉴定出的杂合p.A684V变异似乎是一个热点突变,可能在儿童早期导致重度至极重度听力损失。对于因该变异导致听力障碍的病例,人工耳蜗植入被认为是有利的。